Lovelace and Gilead Discovery of GS-7682
Research_Facility
RSV continues to be a focus area within respiratory health with the release of new vaccines and therapeutics. As leading experts in infectious disease and respiratory drug development the teams at Lovelace and Gilead recently published some work on GS-7682 to target RSV. We are excited about this work as it directly impacts respiratory health. If you have interests in ... Read More The post Lovelace and Gilead Discovery of GS-7682 appeared first on Lovelace Biomedical .